ArticlePloS one2014
NIMEFI: gene regulatory network inference using multiple ensemble feature importance algorithms.
Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- BCTI: a Bayesian network-based method for revealing critical transitions in complex biological systems.PeerJ · 2026Article
- Calculating Enzyme Inhibition with Random Forests.Methods in molecular biology (Clifton, N.J.) · 2026Article
- HSTXGB: a hyperparameter self-tuning XGBoost method integrating pre- and post-processing for gene regulatory network inference.Frontiers in genetics · 2026Article
- Quantifying interventional causality by knockoff operation.Science advances · 2025Article
- GTAT-GRN: a graph topology-aware attention method with multi-source feature fusion for gene regulatory network inference.Frontiers in genetics · 2025Article
- Gene regulatory network analysis identifies MYL1, MDH2, GLS, and TRIM28 as the principal proteins in the response of mesenchymal stem cells to MgComputational and structural biotechnology journal · 2024Article
- SPREd: a simulation-supervised neural network tool for gene regulatory network reconstruction.Bioinformatics advances · 2024Article
- SPREd: A simulation-supervised neural network tool for gene regulatory network reconstruction.bioRxiv : the preprint server for biology · 2023Article
- Article
- Phosphoproteomics data-driven signalling network inference: Does it work?Computational and structural biotechnology journal · 2023Article
- AGRN: accurate gene regulatory network inference using ensemble machine learning methods.Bioinformatics advances · 2023Article
- Fast and accurate inference of gene regulatory networks through robust precision matrix estimation.Bioinformatics (Oxford, England) · 2022Article
- gpuZoo: Cost-effective estimation of gene regulatory networks using the Graphics Processing Unit.NAR genomics and bioinformatics · 2022Article
- FINET: Fast Inferring NETwork.BMC research notes · 2020Article
- Biomarker Prioritisation and Power Estimation Using Ensemble Gene Regulatory Network Inference.International journal of molecular sciences · 2020Article
- Specific functions for Mediator complex subunits from different modules in the transcriptional response of Arabidopsis thaliana to abiotic stress.Scientific reports · 2020Article
- RWRNET: A Gene Regulatory Network Inference Algorithm Using Random Walk With Restart.Frontiers in genetics · 2020Article
- D3GRN: a data driven dynamic network construction method to infer gene regulatory networks.BMC genomics · 2019Article
- Network inference performance complexity: a consequence of topological, experimental and algorithmic determinants.Bioinformatics (Oxford, England) · 2019Article
- Estimation of the proteomic cancer co-expression sub networks by using association estimators.PloS one · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the long-standing open challenges in computational systems biology is the topology inference of gene regulatory networks from high-throughput omics data. Recently, two community-wide efforts, DREAM4 and DREAM5, have been established to benchmark network inference techniques using gene expression measurements. In these challenges the overall top performer was the GENIE3 algorithm. This method decomposes the network inference task into separate regression problems for each gene in the network in which the expression values of a particular target gene are predicted using all other genes as possible predictors. Next, using tree-based ensemble methods, an importance measure for each predictor gene is calculated with respect to the target gene and a high feature importance is considered as putative evidence of a regulatory link existing between both genes. The contribution of this work is twofold. First, we generalize the regression decomposition strategy of GENIE3 to other feature importance methods. We compare the performance of support vector regression, the elastic net, random forest regression, symbolic regression and their ensemble variants in this setting to the original GENIE3 algorithm. To create the ensemble variants, we propose a subsampling approach which allows us to cast any feature selection algorithm that produces a feature ranking into an ensemble feature importance algorithm. We demonstrate that the ensemble setting is key to the network inference task, as only ensemble variants achieve top performance. As second contribution, we explore the effect of using rankwise averaged predictions of multiple ensemble algorithms as opposed to only one. We name this approach NIMEFI (Network Inference using Multiple Ensemble Feature Importance algorithms) and show that this approach outperforms all individual methods in general, although on a specific network a single method can perform better. An implementation of NIMEFI has been made publicly available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.